Stockholm - Free Realtime Quote SEK
AroCell AB (publ) (AROC.ST)
0.6060
+0.0180
+(3.06%)
As of 10:50:33 AM GMT+2. Market Open.
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Anders Hultman B.Sc. | Chief Executive Officer | -- | -- | 1974 |
| Jonas Söderholm | Global Medical Lead | -- | -- | -- |
| Ms. Maria Sundberg | Chief Operations Officer | -- | -- | -- |
| Ms. Leyla Ali Dholey | Chief Scientific Officer | -- | -- | -- |
| Mr. Gustav Sten | Chief Marketing Officer | -- | -- | -- |
| Ms. Jocelyn Akerberg | Chief Quality Officer | -- | -- | -- |
AroCell AB (publ)
- Sector:
- Healthcare
- Industry: Diagnostics & Research
Description
AroCell AB (publ), a vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden. It offers UBC Rapid, a point-of-care test for diagnosis and monitoring of bladder cancer; AroCell TK 210 ELISA, a biomarker for tumor cell; and TUBEX TF, a vitro diagnostic test for detection of acute typhoid fever. The company was formerly known as Xi Bao Research AB and changed its name to AroCell AB (publ) in 2006. AroCell AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.
Corporate Governance
AroCell AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available